Drugs News and Research

RSS

FDA approves targeted therapy for tumors with KRAS mutations

Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.

29 May 2021

FDA seeks $6.5 billion for investments in core food safety, critical public health infrastructure

The U.S. Food and Drug Administration is requesting a total budget of $6.5 billion as part of the President's fiscal year (FY) 2022 budget - a nearly 8% ($477 million) increase over the agency's FY 2021 funding level for investments in critical public health infrastructure, core food safety and medical product safety programs and other vital public health programs.

29 May 2021

Kinase inhibitors could provide an effective way to treat high-risk leukaemia

Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in children.

29 May 2021

New system can measure propofol concentration in patient's blood during surgery

Anesthesia may be an exact science, but it's not yet fully personalized. Anesthesiologists use a variety of methods to calculate the right dose for a given patient: clinical studies, medical databases and laboratory measurements, for example. However, every individual responds to anesthetics in a different way, and there's no way of knowing what that response will be until the anesthetic is administered.

29 May 2021

Healthcare Automation and Digitalization Congress to focus on telehealth, wearable devices, home-based care

Accessible and affordable healthcare is one of the topics of Healthcare Automation and Digitalization Congress.

29 May 2021

Heart Failure 2021 to showcase latest evidence on prevention, management of heart failure

The latest evidence on the prevention and management of heart failure will be showcased at Heart Failure 2021, an online scientific congress of the European Society of Cardiology (ESC).

29 May 2021

Study sheds new light on human brain development

University of Virginia School of Medicine researchers have shed new light on how our brains develop, revealing that the very last step in cell division is crucial for the brain to reach its proper size and function.

29 May 2021

Biden administration signals it’s in no rush to allow Canadian drug imports

The Biden administration said Friday that it has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Donald Trump as a key strategy to control costs.

29 May 2021

Opioids like ‘lean’ permeate hip-hop culture, but dangers are downplayed

Nykerrius Williams knows about the close relationship between hip-hop and opioid use. Williams, 27, an independent rapper from Gibsland, Louisiana, who goes by the name Young Nyke, took oxycodone pills for the first time when he was 16 and has continued patterns of misuse of those pills, as well as Lortabs, Xanax and codeine cough syrups, until recently. To him, it's part of the business.

28 May 2021

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

The Montreal Heart Institute announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine.

28 May 2021

Study explains why it is difficult to withdraw from certain antidepressants

Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.

28 May 2021

Scientists identify many new gene variants that increase risk for depression

In the largest genetic analysis of depression to date, Veterans Affairs researchers identified many new gene variants that increase the risk for depression. The groundbreaking study helps researchers better understand the biological basis of depression and could lead to better drug treatments.

28 May 2021

Researchers develop chemical probe to fight against antibiotic-resistant bacteria

In the perpetual arms races between bacteria and human-made antibiotics, there is a new tool to give human medicine the edge, in part by revealing bacterial weaknesses and potentially by leading to more targeted or new treatments for bacterial infections.

28 May 2021

New tool will help identify the most promising protein molecules for drug development

A cutting-edge digital tool that will make it cheaper, safer and faster for pharmaceutical companies to predict protein stability - a vital step in the development of new medicines - is being rolled out by scientists from the UK's University of Bath through their spin-out company, BLOC Labs.

28 May 2021

Study examines impact of chemotherapy on mechanical properties of prostate cancer cells

Malignant tumor cells undergo mechanical deformation more easily than normal cells, allowing them to migrate throughout the body.

28 May 2021

UC Riverside expert receives NIH grant to pursue research on moderate concussive brain injury

Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, has received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health to further pursue research on moderate concussive brain injury, which results from car accidents or sports-related concussions.

28 May 2021

Drugs News and Research

FDA approves targeted therapy for tumors with KRAS mutations

FDA seeks $6.5 billion for investments in core food safety, critical public health infrastructure

Kinase inhibitors could provide an effective way to treat high-risk leukaemia

New system can measure propofol concentration in patient's blood during surgery

Healthcare Automation and Digitalization Congress to focus on telehealth, wearable devices, home-based care

Heart Failure 2021 to showcase latest evidence on prevention, management of heart failure

Study sheds new light on human brain development

Biden administration signals it’s in no rush to allow Canadian drug imports

Opioids like ‘lean’ permeate hip-hop culture, but dangers are downplayed

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

Study explains why it is difficult to withdraw from certain antidepressants

Scientists identify many new gene variants that increase risk for depression

Researchers develop chemical probe to fight against antibiotic-resistant bacteria

New tool will help identify the most promising protein molecules for drug development

Study examines impact of chemotherapy on mechanical properties of prostate cancer cells

UC Riverside expert receives NIH grant to pursue research on moderate concussive brain injury

Researchers map malaria parasites in unprecedented cellular detail

Early use of biologics is recommended for patients with luminal and fistulizing Crohn's disease

Scientists investigate sex-targeted drug delivery for traumatic brain injuries

Study may help devise new therapies, improve quality of life for Parkinson's patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News